Main > RHEUMATOLOGY > Eosinophilic Granulomatosis with>
Eosinophilic Granulomatosis with>'s subsections
(*) USA Approval Date: 2017. 12.12.
>PolyAngiitis>TREAT.: MepolizuMAb
Company
IL-5 AntAgonist
TradeMark
TradeMark Web-Site
Eosinophilic Granulomatosis with>'s products
This section has no products